By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Rexahn Pharmaceuticals, Inc. 

15245 Shady Grove Road
Suite 455
Rockville  Maryland  20850  U.S.A.
Phone: 240-268-5300 Fax: 240-268-5310


SEARCH JOBS








Company News
Rexahn Pharmaceuticals, Inc. (RNN) Reports Second Quarter 2014 Financial Results And Pipeline Update 8/14/2014 8:11:43 AM
Rexahn Pharmaceuticals, Inc. (RNN) Provides Update On Phase I Supinoxin Trial In Cancer Patients With Solid Tumors 7/18/2014 10:47:19 AM
Rexahn Pharmaceuticals, Inc. (RNN) Reports First Quarter 2014 Financial Results And Pipeline Update 5/15/2014 9:56:42 AM
Rexahn Pharmaceuticals, Inc. (RNN) Announces Additional Data From Preclinical Studies Of RX-3117 5/8/2014 10:57:18 AM
Rexahn Pharmaceuticals, Inc. (RNN) Presents Data From Preclinical Studies Of RX-21101 4/21/2014 9:13:05 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present Data On RX-3117 And RX-21101 At The 2014 American Association for Cancer Research Annual Meeting 4/2/2014 7:54:04 AM
Rexahn Pharmaceuticals, Inc. (RNN) Reports Fourth Quarter And Full-Year 2013 Financial Results And Recent Highlights 3/24/2014 9:34:24 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum In New York 3/17/2014 8:36:37 AM
Rexahn Pharmaceuticals, Inc. (RNN) Announces Initial Results From Phase I Trial Of Supinoxintm (RX-5902) For Solid Cancer Tumors 3/11/2014 9:08:41 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The 26th Annual ROTH Conference 3/4/2014 8:17:39 AM
12345678910...
//-->